The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
about
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The combination of serum insul ...... e cancer- an exploratory study
@ast
The combination of serum insul ...... e cancer- an exploratory study
@en
The combination of serum insul ...... e cancer- an exploratory study
@nl
type
label
The combination of serum insul ...... e cancer- an exploratory study
@ast
The combination of serum insul ...... e cancer- an exploratory study
@en
The combination of serum insul ...... e cancer- an exploratory study
@nl
prefLabel
The combination of serum insul ...... e cancer- an exploratory study
@ast
The combination of serum insul ...... e cancer- an exploratory study
@en
The combination of serum insul ...... e cancer- an exploratory study
@nl
P2093
P2860
P3181
P1433
P1476
The combination of serum insul ...... e cancer- an exploratory study
@en
P2093
Amado J Zurita
Christopher J Logothetis
Farshid Dayyani
Gary E Gallick
Graciela M Nogueras-González
John C Araujo
Paul G Corn
Randall E Millikan
Rebecca Slack
P2860
P2888
P3181
P356
10.1186/S12885-016-2723-1
P407
P577
2016-09-06T00:00:00Z
P6179
1017340741